Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Avery Dennison
AVY
$12.9B
| $35.4M | 0.08% |
565,500
+390,500
| +223% | +$24.7M |
|
|
PGTI
302
DELISTED
PGT, Inc.
PGTI
| $35.3M | 0.08% |
3,103,329
-142,300
| -4% | -$1.69M |
|
303
Commault Systems
CVLT
$4.97B
| $35.3M | 0.08% |
897,104
-287,696
| -24% | -$11.2M |
|
304
Berkshire Hathaway Class B
BRK.B
$1.11T
| $35M | 0.08% |
265,000
-241,800
| -48% | -$32.5M |
|
305
Philip Morris
PM
$312B
| $35M | 0.08% |
397,800
+321,300
| +420% | +$27.9M |
|
|
JWN
306
DELISTED
Nordstrom
JWN
| $35M | 0.08% |
702,000
+517,500
| +280% | +$31.4M |
|
|
307
Teva Pharmaceuticals
TEVA
$36.9B
| $35M | 0.08% |
532,500
-2,346,263
| -82% | -$145M |
|
308
EXL Service
EXLS
$4.66B
| $34.9M | 0.08% |
3,887,375
+134,375
| +4% | +$1.17M |
|
309
Hilton Worldwide
HLT
$73.4B
| $34.9M | 0.08% |
543,633
-15,334
| -3% | -$1.09M |
|
310
AbbVie
ABBV
$465B
| $34.5M | 0.08% |
582,756
-2,351,000
| -80% | -$135M |
|
|
SPR
311
DELISTED
Spirit AeroSystems
SPR
| $34.4M | 0.07% |
686,600
-68,900
| -9% | -$3.52M |
|
|
ALR
312
DELISTED
Alere Inc
ALR
| $34.3M | 0.07% |
878,424
-235,000
| -21% | -$10.1M |
|
313
Union Pacific
UNP
$175B
| $34.3M | 0.07% |
+438,900
| New | +$37.7M |
|
314
Photronics
PLAB
$1.72B
| $34.2M | 0.07% |
2,747,295
+1,056,400
| +62% | +$11.4M |
|
315
Robert Half
RHI
$4.04B
| $34M | 0.07% |
720,200
+552,240
| +329% | +$27.9M |
|
316
Pan American Silver
PAAS
$18.2B
| $33.9M | 0.07% |
5,216,800
+524,600
| +11% | +$3.77M |
|
|
LTXB
317
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $33.9M | 0.07% |
1,354,581
-37,418
| -3% | -$1.08M |
|
|
AWH
318
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $33.9M | 0.07% |
910,600
+361,233
| +66% | +$13.3M |
|
|
WBMD
319
DELISTED
WebMD Health Corp.
WBMD
| $33.6M | 0.07% |
695,980
+272,880
| +64% | +$12.2M |
|
320
Home Depot
HD
$343B
| $33.4M | 0.07% |
+252,200
| New | +$32.1M |
|
321
Rollins
ROL
$18.8B
| $33.2M | 0.07% |
2,883,375
+44,550
| +2% | +$531K |
|
|
DENN
322
DELISTED
Denny's
DENN
| $33.1M | 0.07% |
3,368,100
-121,477
| -3% | -$1.25M |
|
323
Alexandria Real Estate Equities
ARE
$9.41B
| $33.1M | 0.07% |
365,900
+80,180
| +28% | +$7.25M |
|
324
Campbell Soup
CPB
$6.8B
| $33M | 0.07% |
628,800
+394,400
| +168% | +$20.2M |
|
325
Exelon
EXC
$48.4B
| $32.8M | 0.07% |
1,657,338
+1,577,390
| +1,973% | +$32M |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.